HE4 as a serum biomarker for the diagnosis of pelvic masses: A prospective, multicenter study in 965 patients

To evaluate the diagnostic value of adding human epididymis protein 4 (HE4), cancer antigen 125 (CA125) and risk of malignancy algorithm (ROMA) to ultrasound for detecting ovarian cancer in patients with a pelvic mass.